# Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1

> **NCT05238909** · — · ENROLLING_BY_INVITATION · sponsor: **Ann & Robert H Lurie Children's Hospital of Chicago** · enrollment: 200 (estimated)

## Conditions studied

- Neurofibromatosis 1
- NF1
- Neurofibromatosis Type 1

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05238909
- **Lead sponsor:** Ann & Robert H Lurie Children's Hospital of Chicago
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-03-04
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-09-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05238909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05238909, "Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05238909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*